|
|
Volumn 289, Issue 5484, 2000, Pages 1508-1514
|
|
Therapeutic approaches to bone diseases
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
[1 HYDROXY 2 (IMIDAZO[1,2 A]PYRIDIN 3 YL)ETHYLIDENE]BISPHOSPHONIC ACID;
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CATHEPSIN K;
CLODRONIC ACID;
EB 1053;
ESTROGEN DERIVATIVE;
ETIDRONIC ACID;
FIBROBLAST GROWTH FACTOR;
IBANDRONIC ACID;
INCADRONIC ACID;
NERIDRONIC ACID;
OLPADRONIC ACID;
OSTEOCLAST DIFFERENTIATION FACTOR;
OSTEOPROTEGERIN;
PAMIDRONIC ACID;
PARATHYROID HORMONE;
RALOXIFENE;
RISEDRONIC ACID;
SOMATOMEDIN;
TAMOXIFEN;
TILUDRONIC ACID;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ZOLEDRONIC ACID;
BONE CANCER;
BONE DISEASE;
BONE METABOLISM;
CELL ACTIVITY;
CELL DIFFERENTIATION;
DRUG EFFECT;
DRUG INDUCED DISEASE;
DRUG STRUCTURE;
ESTROGEN DEFICIENCY;
FRACTURE;
GENE THERAPY;
HORMONAL THERAPY;
HUMAN;
NONHUMAN;
OSSIFICATION;
OSTEOLYSIS;
OSTEOPOROSIS;
PAGET BONE DISEASE;
PERIODONTAL DISEASE;
PRIORITY JOURNAL;
REVIEW;
RHEUMATOID ARTHRITIS;
ANIMALS;
BONE DISEASES;
BONE RESORPTION;
CALCITONIN;
DIPHOSPHONATES;
ESTROGEN RECEPTOR MODULATORS;
ESTROGENS;
FEMALE;
GENE THERAPY;
GROWTH SUBSTANCES;
HUMANS;
MALE;
OSTEOCLASTS;
OSTEOGENESIS;
OSTEOPOROSIS;
PARATHYROID HORMONE;
|
|
EID: 0034284550
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.289.5484.1508 Document Type: Review |
|
Times cited : (1562)
|
|
References (107)
|
